These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27329763)

  • 1. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B
    Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
    West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
    Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice.
    Ghazi-Noori S; Froud KE; Mizielinska S; Powell C; Smidak M; Fernandez de Marco M; O'Malley C; Farmer M; Parkinson N; Fisher EM; Asante EA; Brandner S; Collinge J; Isaacs AM
    Brain; 2012 Mar; 135(Pt 3):819-32. PubMed ID: 22366797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia.
    Fort-Aznar L; Ugbode C; Sweeney ST
    Hum Mol Genet; 2020 Sep; 29(16):2637-2646. PubMed ID: 32628265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
    Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
    PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
    Cheruiyot A; Lee JA; Gao FB; Ahmad ST
    FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias.
    Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB
    Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
    Ugbode C; West RJH
    Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
    López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
    Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
    Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.